Login to Your Account



Onyx Wins Accelerated Nod for Myeloma Drug Kyprolis

By Jennifer Boggs
Managing Editor

Monday, July 23, 2012

Shares of Onyx Pharmaceuticals Inc. jumped 11.7 percent Friday after its multiple myeloma drug Kyprolis (carfilzomib) won accelerated approval as a third-line treatment.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription